| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |